Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-054539
Filing Date
2012-10-11
Accepted
2012-10-11 19:58:44
Documents
1
Period of Report
2012-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd358151.html 4  
1 FORM 4 rrd358151.xml 4 5177
  Complete submission text file 0001181431-12-054539.txt   6876
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Reporting) CIK: 0001178670 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 121140882
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations